Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Neuropeptides|December 1, 1984
Electroencephalographic assessment of the role of delta receptors in opioid peptide - induced seizuresF C Tortella, L Robles, H I Mosberg, et al.
European Journal of Pharmacology|December 3, 1981
Opiate-like electroencephalographic and behavioral effects of electroconvulsive shock in ratsF C Tortella, A Cowan, G L Belenky, et al.
Brain Research|December 15, 1995
Role of calcium in sigma-mediated neuroprotection in rat primary cortical neuronsK L Klette, M A DeCoster, J E Moreton, et al.
Neuroreport|September 1, 1992
Calcium dynamics in neurons treated with toxic and non-toxic concentrations of glutamateM A DeCoster, M L Koenig, J C Hunter, et al.
Brain Research|February 6, 1995
Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal culturesM A DeCoster, K L Klette, E S Knight, et al.
Brain Research|December 18, 2001
Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemiaW L Bao, A J Williams, A I Faden, et al.
Neuroreport|November 21, 1994
The neuroprotective kappa-opioid CI-977 alters glutamate-induced calcium signaling in vitroM A DeCoster, J R Conover, J C Hunter, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious ratsK Dosaka-Akita, F C Tortella, J W Holaday, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1994
Neurotoxicity of artemisinin analogs in vitroD L Wesche, M A DeCoster, F C Tortella, et al.
Life Sciences|January 1, 1990
PD117302, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in ratsF C Tortella, L Robles, E Echevarria, et al.
Pageof 9